vs
Side-by-side financial comparison of EXACT SCIENCES CORP (EXAS) and PureTech Health plc (PRTC), based on the latest 10-Q / 10-K filings. Click either name above to swap in a different company.
Exact Sciences Corporation is an American molecular diagnostics company based in Madison, Wisconsin, specializing in the detection of early-stage cancers. The company provides products for the detection and prevention of colorectal cancer, including Cologuard, the first stool DNA test for colorectal cancer, along with additional screening and precision oncological tests for other types of cancer.
PureTech Health is an American biotechnology company which develops medicines to combat serious diseases. It is listed on the London Stock Exchange.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history — bar widths are scaled to the larger of the two companies so you can eyeball the size gap and growth trajectory without doing math. Quarters aligned by calendar period (report date) so offset fiscal years line up.
| Q4 25 | $878.4M | — | ||
| Q3 25 | $850.7M | — | ||
| Q2 25 | $811.1M | — | ||
| Q1 25 | $706.8M | — | ||
| Q4 24 | $713.4M | — | ||
| Q3 24 | $708.7M | — | ||
| Q2 24 | $699.3M | — | ||
| Q1 24 | $637.5M | — |
| Q4 25 | $-86.0M | — | ||
| Q3 25 | $-19.6M | — | ||
| Q2 25 | $-1.2M | — | ||
| Q1 25 | $-101.2M | — | ||
| Q4 24 | $-864.6M | — | ||
| Q3 24 | $-38.2M | — | ||
| Q2 24 | $-15.8M | — | ||
| Q1 24 | $-110.2M | — |
| Q4 25 | 70.1% | — | ||
| Q3 25 | 68.6% | — | ||
| Q2 25 | 69.3% | — | ||
| Q1 25 | 70.8% | — | ||
| Q4 24 | 69.0% | — | ||
| Q3 24 | 69.4% | — | ||
| Q2 24 | 69.8% | — | ||
| Q1 24 | 70.0% | — |
| Q4 25 | -9.4% | — | ||
| Q3 25 | -3.0% | — | ||
| Q2 25 | -0.3% | — | ||
| Q1 25 | -13.6% | — | ||
| Q4 24 | -122.8% | — | ||
| Q3 24 | -5.6% | — | ||
| Q2 24 | -3.8% | — | ||
| Q1 24 | -16.7% | — |
| Q4 25 | -9.8% | — | ||
| Q3 25 | -2.3% | — | ||
| Q2 25 | -0.1% | — | ||
| Q1 25 | -14.3% | — | ||
| Q4 24 | -121.2% | — | ||
| Q3 24 | -5.4% | — | ||
| Q2 24 | -2.3% | — | ||
| Q1 24 | -17.3% | — |
| Q4 25 | $-0.45 | — | ||
| Q3 25 | $-0.10 | — | ||
| Q2 25 | $-0.01 | — | ||
| Q1 25 | $-0.54 | — | ||
| Q4 24 | $-4.69 | — | ||
| Q3 24 | $-0.21 | — | ||
| Q2 24 | $-0.09 | — | ||
| Q1 24 | $-0.60 | — |
Financial Flow Comparison
Sankey diagram of revenue → gross profit → operating profit → net profit for each company. Charts shown full-width and stacked so both segment hierarchies are readable side-by-side on desktop and mobile.
